Cargando…

Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension

BACKGROUND: To assess the use of updated comorbidity information over time on ability to predict mortality among adults with newly diagnosed hypertension. METHODS: We studied adults 18 years and older with an incident diagnosis of hypertension from Alberta, Canada. We compared the prognostic perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Rymkiewicz, Peter, Ravani, Pietro, Hemmelgarn, Brenda R., McAlister, Finlay A., Southern, Danielle A., Walker, Robin, Chen, Guanmin, Quan, Hude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120518/
https://www.ncbi.nlm.nih.gov/pubmed/27876047
http://dx.doi.org/10.1186/s12913-016-1910-8
_version_ 1782469257398845440
author Rymkiewicz, Peter
Ravani, Pietro
Hemmelgarn, Brenda R.
McAlister, Finlay A.
Southern, Danielle A.
Walker, Robin
Chen, Guanmin
Quan, Hude
author_facet Rymkiewicz, Peter
Ravani, Pietro
Hemmelgarn, Brenda R.
McAlister, Finlay A.
Southern, Danielle A.
Walker, Robin
Chen, Guanmin
Quan, Hude
author_sort Rymkiewicz, Peter
collection PubMed
description BACKGROUND: To assess the use of updated comorbidity information over time on ability to predict mortality among adults with newly diagnosed hypertension. METHODS: We studied adults 18 years and older with an incident diagnosis of hypertension from Alberta, Canada. We compared the prognostic performance of Cox regression models using Charlson comorbidities as time-invariant covariates at baseline (TIC) versus models including Charlson comorbidities as time-varying covariates (TVC) using Akaike Information Criterion (AIC) for testing goodness of fit. RESULTS: The strength of the association between important prognostic clinical variables and mortality varied by modeling technique; for example, myocardial infarction was less strongly associated with mortality in the TIC model (Hazard Ratio 1.07; 95% Confidence Interval (CI): 1.05 to 1.1) than in the TVC model (HR 1.20; 95% CI: 1.18 to 1.22). All TVC models slightly outperformed TIC models, regardless of the method used to adjust for comorbid conditions (individual Charlson Comorbidities, count of comorbidities or indices). The TVC model including all 17 Charlson comorbidities as individual independent variables showed the best fit and performance. CONCLUSION: Accounting for changes in patient comorbidity status over time more accurately captures a patient’s health risk and slightly improves predictive model fit and performance than traditional methods using TIC assessment.
format Online
Article
Text
id pubmed-5120518
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51205182016-11-28 Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension Rymkiewicz, Peter Ravani, Pietro Hemmelgarn, Brenda R. McAlister, Finlay A. Southern, Danielle A. Walker, Robin Chen, Guanmin Quan, Hude BMC Health Serv Res Research Article BACKGROUND: To assess the use of updated comorbidity information over time on ability to predict mortality among adults with newly diagnosed hypertension. METHODS: We studied adults 18 years and older with an incident diagnosis of hypertension from Alberta, Canada. We compared the prognostic performance of Cox regression models using Charlson comorbidities as time-invariant covariates at baseline (TIC) versus models including Charlson comorbidities as time-varying covariates (TVC) using Akaike Information Criterion (AIC) for testing goodness of fit. RESULTS: The strength of the association between important prognostic clinical variables and mortality varied by modeling technique; for example, myocardial infarction was less strongly associated with mortality in the TIC model (Hazard Ratio 1.07; 95% Confidence Interval (CI): 1.05 to 1.1) than in the TVC model (HR 1.20; 95% CI: 1.18 to 1.22). All TVC models slightly outperformed TIC models, regardless of the method used to adjust for comorbid conditions (individual Charlson Comorbidities, count of comorbidities or indices). The TVC model including all 17 Charlson comorbidities as individual independent variables showed the best fit and performance. CONCLUSION: Accounting for changes in patient comorbidity status over time more accurately captures a patient’s health risk and slightly improves predictive model fit and performance than traditional methods using TIC assessment. BioMed Central 2016-11-22 /pmc/articles/PMC5120518/ /pubmed/27876047 http://dx.doi.org/10.1186/s12913-016-1910-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rymkiewicz, Peter
Ravani, Pietro
Hemmelgarn, Brenda R.
McAlister, Finlay A.
Southern, Danielle A.
Walker, Robin
Chen, Guanmin
Quan, Hude
Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension
title Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension
title_full Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension
title_fullStr Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension
title_full_unstemmed Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension
title_short Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension
title_sort effects of longitudinal changes in charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120518/
https://www.ncbi.nlm.nih.gov/pubmed/27876047
http://dx.doi.org/10.1186/s12913-016-1910-8
work_keys_str_mv AT rymkiewiczpeter effectsoflongitudinalchangesincharlsoncomorbidityonprognosticsurvivalmodelperformanceamongnewlydiagnosedpatientswithhypertension
AT ravanipietro effectsoflongitudinalchangesincharlsoncomorbidityonprognosticsurvivalmodelperformanceamongnewlydiagnosedpatientswithhypertension
AT hemmelgarnbrendar effectsoflongitudinalchangesincharlsoncomorbidityonprognosticsurvivalmodelperformanceamongnewlydiagnosedpatientswithhypertension
AT mcalisterfinlaya effectsoflongitudinalchangesincharlsoncomorbidityonprognosticsurvivalmodelperformanceamongnewlydiagnosedpatientswithhypertension
AT southerndaniellea effectsoflongitudinalchangesincharlsoncomorbidityonprognosticsurvivalmodelperformanceamongnewlydiagnosedpatientswithhypertension
AT walkerrobin effectsoflongitudinalchangesincharlsoncomorbidityonprognosticsurvivalmodelperformanceamongnewlydiagnosedpatientswithhypertension
AT chenguanmin effectsoflongitudinalchangesincharlsoncomorbidityonprognosticsurvivalmodelperformanceamongnewlydiagnosedpatientswithhypertension
AT quanhude effectsoflongitudinalchangesincharlsoncomorbidityonprognosticsurvivalmodelperformanceamongnewlydiagnosedpatientswithhypertension